<bill session="115" type="s" number="1049" updated="2017-06-19T22:15:21Z">
  <state datetime="2017-05-04">REFERRED</state>
  <status>
    <introduced datetime="2017-05-04"/>
  </status>
  <introduced datetime="2017-05-04"/>
  <titles>
    <title type="short" as="introduced">Opioid Addiction Risk Transparency Act</title>
    <title type="short" as="introduced">Opioid Addiction Risk Transparency Act</title>
    <title type="official" as="introduced">A bill to allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling.</title>
    <title type="display">Opioid Addiction Risk Transparency Act</title>
  </titles>
  <sponsor id="412680"/>
  <cosponsors>
    <cosponsor id="412428" joined="2017-05-04"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-05-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="115" type="s" number="934"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
